Stockscreener 앱 받기
0.0111
0.00%
0.00
전일 마감가:
$0.0111
열려 있는:
$0.0111
하루 거래량:
594
Relative Volume:
2.35
시가총액:
$N/A
수익:
$547.00K
순이익/손실:
$-34.02M
주가수익비율:
-0.000237
EPS:
-46.9127
순현금흐름:
$-27.11M
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
-95.56%
1년 성능:
+221.67%
1일 변동 폭
$0.0111
$0.0111
1주일 범위
$0.0111
$0.0111
52주 변동 폭
$0.01
$1.15
Trevena Inc Stock (TRVN) Company Profile
Compare TRVN vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVN
Trevena Inc
|
0.0111 | 0 | 547.00K | -34.02M | -27.11M | -46.91 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-15 | 개시 | Oppenheimer | Perform |
| 2020-09-14 | 개시 | Guggenheim | Buy |
| 2020-08-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-31 | 재개 | H.C. Wainwright | Buy |
| 2018-11-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-10-12 | 다운그레이드 | Needham | Buy → Hold |
| 2018-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-11-08 | 재확인 | Needham | Buy |
| 2017-10-16 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2017-10-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-08 | 재확인 | Needham | Buy |
| 2017-02-23 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-22 | 재확인 | FBR & Co. | Outperform |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-09 | 개시 | H.C. Wainwright | Buy |
| 2017-01-05 | 개시 | Oppenheimer | Outperform |
| 2016-05-17 | 재확인 | FBR Capital | Outperform |
| 2016-05-17 | 재확인 | Needham | Buy |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2015-09-01 | 재확인 | Wedbush | Outperform |
| 2015-08-03 | 개시 | Brean Capital | Buy |
모두보기
Trevena Inc 주식(TRVN)의 최신 뉴스
Verastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
Trevena (STU:6T4) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
SMX (Security Matters) Public Limited CompanyOrdinary Shares (NQ: SMX - The Chronicle-Journal
Wall Street closes lower, as war on Iran fuels inflation worries - marketscreener.com
S&P Closes Out Third Straight Week of Loses | Closing Bell - marketscreener.com
US Stocks Brief: S&P Futures Down 0.25% - marketscreener.com
Elon Musk's SpaceX weighs Nasdaq listing, sources say - marketscreener.com
Celebrity-studded Caliwater bets cactus is next big wave in hydration - Food Dive
Wall Street opens lower as investors weigh Middle East war risks - marketscreener.com
TRVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Trump Says Stock Market Hit 53 New Highs on His Watch - marketscreener.com
US software stocks climb as Anthropic announcement sparks relief rally - marketscreener.com
VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
U.S. S&P 500 E-mini and Nasdaq 100 futures flat, Dow futures down 0.1% - marketscreener.com
Wall Street ends higher, lifted by Nvidia and other AI stocks - marketscreener.com
Tg-17 Inc changes corporate name to Our Bond, Inc. - marketscreener.com
Coinshares Updates on Fourth Quarter, Plans $0.33 Dividend Per Share - marketscreener.com
Investor Increases its Stake in Nasdaq - marketscreener.com
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Intellectia AI
Novakand Pharma applies for Nasdaq's approval of continued listing - marketscreener.com
S&P 500, Nasdaq turn negative; S&P down 0.4%, Nasdaq falls 0.9% - marketscreener.com
Braiin Shares to Begin Trading on Nasdaq - marketscreener.com
Columbus Circle Capital Corp II Prices $200 Million Initial Public Offering - marketscreener.com
Sanofi Concludes $2.2 Billion Takeover of Dynavax Technologies - marketscreener.com
Spring Valley Acquisition Corp. IV Prices $200 Million IPO - marketscreener.com
Unique Global Innovative Solutions Corp. (Ugiz) announces intent to pursue Nasdaq uplisting and capital raise - marketscreener.com
Generate Biomedicines Inc announces initial public offering - marketscreener.com
RCI Hospitality Receives Non-Compliance Letter from Nasdaq - marketscreener.com
Earnings Flash (NDAQ) Nasdaq Posts Q4 Revenue $2.80B - marketscreener.com
Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire
North American Morning Briefing : Nasdaq Futures Rise; Trade Relations, Earnings in Focus -2 - marketscreener.com
Trevena (NASDAQ:TRVN) Share Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
What technical patterns form on Trevena Inc. (6T4) stock chartsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - bollywoodhelpline.com
Trevena Restructures China Royalty Rights to Exit Debt - The Globe and Mail
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) - Defense World
Trevena Signs Assignment and Release Agreement With R-Bridge Investment Four and Jiangsu Nhwa Pharmaceutical - TradingView — Track All Markets
Trevena (NASDAQ:TRVN) Shares Cross Below Fifty Day Moving Average – Here’s What Happened - Defense World
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - BioSpace
How Trevena Inc. (6T4) stock valuation compares with sectorQuarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Analyst Upgrade: How Trevena Inc. (6T4) stock benefits from digital adoptionJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Published on: 2026-01-09 03:04:06 - ulpravda.ru
Published on: 2026-01-09 00:14:30 - ulpravda.ru
RMTICurrent Report Filing (8-k) - ADVFN
Trevena Inc. (TRVN) Stock Price | Live Quotes & Charts | EXPM - StocksToTrade
Integrated Media Receives Nasdaq Noncompliance Notice Over Minimum Bid Price Requirement - marketscreener.com
S&P 500, Nasdaq extend gains, Dow turns positive - marketscreener.com
Trevena Inc (TRVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
1.47%
자본화:
|
볼륨(24시간):